
山沉香超微粉与普通粉抗心肌缺血对比研究
A comparative study of anti myocardial ischemia in mountain aloes superfine and common powder
目的:研究蒙药山沉香超微粉抗心肌缺血的药理学作用,并与山沉香原粉作对比研究。方法:采用冠脉结扎方法观察山沉香对心肌缺血大鼠心脏的保护作用(测定心梗面积、心电图、血清牛肌酸激酶(CK)、超氧化物歧化酶(SOD)、乳酸盐脱氢酶(LDH)及病理组织观察)。结果:山沉香超微粉和原粉均有不同程度的大鼠心肌缺血保护作用:可降低大鼠血清CK、LDH的含量,升高血清SOD的含量,并能减小心肌缺血的面积,明显改善心电图,且超微粉0.75,0.375 g·kg-1剂量组明显优于原粉(P<0.05);超微粉0.125 g·kg-1剂量组相当于原粉0.75 g·kg-1剂量组(P>0.05)。结论:相同剂量,山沉香超微粉保护心肌缺血作用优于原粉,1/2,1/4剂量超微粉保护心肌缺血作用与原粉相当。
OBJECTIVE to Mongolian studies mountain aloes ultrafine powder of anti myocardial ischemia pharmacological effects, and with hill incense powder for comparative study.METHODS the coronary artery ligation method observation Hill incense on myocardial ischemia in the rat heart protective effect (a measure of area of myocardial infarction, electrocardiogram, serum CK, LDH, SOD and pathological observation).RESULTS Mountain aloes super powder and raw powders had different degrees of rat myocardial ischemia:decrease of serum CK, LDH and increased the content of serum SOD content, and can reduce the area of myocardial ischemia, significantly improve the ECG and super micropowder 0.75, 0.375 g·kg-1 dose group was significantly better than the original powder (P<0.05); ultra fine powder 0.125 g·kg-1 dose group is in the original powder 0.75 g·kg-1 dose group (P>0.05).CONCLUSION the same dose, the mountain aloes super micropowder myocardial protection ischemia effect is better than that of the original powder, 1/2, 1/4 dose super micropowder protect myocardial ischemia with raw powder.
山沉香 / 超微粉 / 原粉 / 心肌缺血 {{custom_keyword}} /
Mountain incense / ultrafine powder / powder / myocardial ischemia {{custom_keyword}} /
[1] 中华人民共和国卫生部药品标准蒙药分册[S]. 1998.
[2] 张国彬,刘利军,李明奎,等.山沉香挥发油成分的研究[J].中国药学杂志,1994,29(5):271-273.
[3] 谢瑞红,王顺喜,谢建新,等.超微粉碎技术的应用现状与发展趋势[J].中国粉体技术,2009,15(3):64-67.
[4] 张海英,聂继红.丹参超微粉和细粉中丹酚酸B的溶出度研究[J].安徽农业科学,2013,41(9):4054-4056.
[5] 姚秋萍,俞道进,李健,等.油菜花粉超微粉有效成分山奈酚在家兔的药代动力学研究[J].营养学报,2012,4:150-153.
[6] 刘云海,杜光超.微粉碎对中药活性成分提取率的影响[J].中国医院药学杂志,2010,30(1):66-69.
[7] 朱莉,隆泉,郑保忠.超微粉碎技术及其在中药生产中的应用[J].云南大学学报,2004(26):128-131.
[8] 陈开文,谭涌.中药超微粉碎应用概况[J].中国药业,2006,15(2):75-761.
[9] Wu ZY, Benoit JN. Effects of propranolol on intestinal microcirculation of normal and portal hypertensive rats[J]. J Hepatol, 1995, 22(6):677-684.
[10] Daull P, Blouin A, Sirois P, et al. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats[J]. J Cardiovasc Pharmacol, 2004,44(Suppl1):S398-S401.
[11] Ling H, Lou Y. Total flavones from Elsholtzia blanda reduce infarct size during acute myocardial ischemia by inhibiting myocardial apoptosis in rats[J]. J Ethnopharmacol, 2005, 101(1/3):169-175.
[12] Sumitra M, Manikandan P, Kumar DA, et al. Experimental myocardial necrosis in rats:Role of arjunolic acid on platelet aggregation,coagulation and antioxidant status[J]. Mol Cell Biochem, 2001, 224(1-2):135-142.
[13] 鞠爱华,庄志鹤,蔡丽娟,等.蒙药山沉香超微粉与普通粉中总木脂素体外溶出度比较[J].时珍国医国药,2015,27(1):89-91.
[14] 颜彦.蒙药山沉香挥发油成分分析及抗心肌缺血作用研究[D].华中科技大学,2011.
国家科技部支撑计划蒙药产业化共性关键技术研究项目(编号:2012BI28B01)
/
〈 |
|
〉 |